Robin White joined the CPC team in 2016 and has been instrumental in taking the CPC Biostatics and Programming team into ever increasing levels of excellence.
With over 30 years industry experience in the design, analyses, interpretation and reporting of clinical trial data, Ms. White brings extraordinary expertise to the leadership of CPC. She has proven abilities in both the management of statistical teams and in delivering a quality product to move projects forward. Among her many achievements, Ms. White was awarded a Pipeline Award for outstanding contribution to first time approval of a new epilepsy compound while at GlaxoSmithKline Inc. Included in her experience are many years of successfully interacting with FDA and worldwide regulatory agencies on new drug approvals and post marketing studies.
Ms. White understands the needs and importance of our client’s projects and strives to provide strategic leadership and operational efficiencies to help our clients succeed.